Let's hope it doesn't follow the NWBO pattern: people pumped that to boards I was on for years ($2 --> $1.50 --> $1.00 --> $0,50 --> $0.40 --> $0.28 today.
I don't think it will follow that pattern because 2-73 and 3-71 seem to actually work to help patients. With MAA accepted the stock should finally break $12 and if the 3-71 schizophrenia data is good next Summer then maybe breaks through over $20 even as EMA approval looms.